Icon

EVOMELA (nda207155)- (EQ 50MG BASE/VIAL)

MELPHALAN HYDROCHLORIDE ACROTECH BIOPHARMA
EQ 50MG BASE/VIAL
Yes Yes
2034-Jan-30 Expired
2023-Mar-10 None
None No
Evomela is an alkylating drug indicated for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma.
0 0 0
Total Other Developers 9
Drugs with Suitability No
EQ 50MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.